Global Auto Injectors Market is projected to Value Over USD 86.3 Billion by 2026 End

  • 25 Sep 2019

Global Auto Injectors Market is projected to value over USD 86.3 billion by 2026 end and register a CAGR of over 20.1% during the forecast period 2019 to 2026


Auto-injectors offer multiple advantages like the reduction of phobia-related anxiety associated with needles, maintain dose accuracy consistency, assist in better efficacy, reduce chances of needle stick injuries, thus aiding growth. Auto-injectors deliver drugs in a controlled manner when compared to manual injection.


The nature of the drug decides what should be the injecting site of that particular drug. Auto-injectors induce less pain in comparison with syringes, thus increasing their demand. Although, availability of options like oral tablets may restrain the market growth.


Device functions are anticipated to receive some vital upgrades which shall bolster the global auto injectors market growth. For example, Bayer HealthCare announced an electronic auto-injector that shall be used for treating relapsing multiple sclerosis, which provides complete drug dosage for compliance improvement and thus reduces the total cost. The SHL group provides different types of auto-injectors with high viscosity and large volumes.


The market is bifurcated based on product as reusable and disposable auto-injectors. In 2018, the disposable auto-injectors segment held the largest global auto injectors market share owing to its easy usage, patient’s preference and convenience.


Reusable auto-injectors are of two types, empty and prefilled auto-injectors. Prefilled auto-injectors was the largest market segment and is predicted to showcase dominance during the forecast period. They come with standard barrels which are prefilled and which contain therapeutic drugs. The biggest advantage offered by these prefilled syringes is they eliminate errors that occur during the provision of dosage.


On the basis of disease indication, the global auto injectors market is categorized as diabetes, anaphylaxis, multiple sclerosis, rheumatoid arthritis, and other therapies. The anaphylaxis segment held the largest market share in 2018. This substantial market share can be credited to the rising prevalence of anaphylactic reactions due to insect stings, medications, food and latex.


According to the Asthma and Allergy Foundation of America (AAFA), the health issue that usually affects children in the U.S is allergic conditions. Over 8.5 million children suffered from skin allergies and over 4 million suffered from food allergies in 2015. It is also the most persistent disease in Europe. Over 15% of patients suffering from allergies fear from a possible asthma attack, anaphylactic shock, or even death from these allergic reactions.


North America subjugated the market in 2018 and is anticipated to consistently dominate over the forecast period. This can be credited to technological advancements in medical devices, high demand for quality products and advanced infrastructure for healthcare. According to the Asthma and Allergy Foundation of America, allergy is the sixth cause of persistent illness in the United States. As per the Food Allergy Research and Education, over 150,000 people need emergency medical care for food-related allergic reactions every year. Therefore, the aforementioned factors are predicted to stimulate demand of the market in the region.


Key market players included in the global auto injectors market industry are Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton, Dickinson and Co., Owen Mumford, Consort Medical, Haselmeir, Shl Group, Johnson & Johnson, Teva, Antares Pharma.


Global Auto Injectors Market Segmentation:

By Therapy

· Rheumatoid Arthritis

· Multiple Sclerosis

· Diabetes

· Anaphylaxis

· Other Therapies


By Type

· Disposable Auto Injectors

· Reusable Auto Injectors


By End User

· Home Care Settings

· Hospitals & Clinics


By Region

· North America

· Europe

· Asia Pacific

· Rest of the World


FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 


Objectives of the Study:

  • To provide with an exhaustive analysis on the global auto injectors market by therapy, by type, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact